CompoAtlas

Liberdigest transit favorisé

Food supplement declared in France, decision dated 18 June 2026

Liberdigest transit favorisé, from LES TROIS CHENES, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: inulines 800 mg per day, Malva sylvestris 750 mg per day, Plantago afra 500 mg per day, Salvia hispanica 200 mg per day, Melissa officinalis 140 mg per day. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
not provided
Food business operator placing the product on the market
LES TROIS CHENES
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Sachet
Daily dose
1
Intended populations
General population
Not recommended (according to the manufacturer)
Breastfeeding women, Children (under 12), Pregnant women, Taking medication
Objectives stated by the manufacturer (these are not authorised claims)
Bowel regularity, Digestion

Declaration 362721, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Malva sylvestris L.FeuilleExtrait sec aqueux750 mg
Plantago afra L.GraineExtrait sec aqueux500 mg
Salvia hispanica L.GrainePoudre (de plantes séchées ou broyées)200 mg
Melissa officinalis L.FeuilleExtrait sec aqueux140 mg

Substances

NamePer day
inulines800 mg

Micro-organisms

StrainPer day
Lactobacillus Paracasei 327not declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
magnesium oxideMagnesium250 mg300 mg

Additives

E330, E420

Other ingredients

Jus de betterave

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Label warnings

Déconseillé en cas de pathologie digestive avérée, ou saignement rectal inexpliqué et en cas de difficulté à avaler. Déconseillé aux femmes enceintes et allaitantes et aux enfants de moins de 12 ans. Demander conseil à un professionnel de santé en cas de traitement médicamenteux.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Melissa officinalis L.
    Read the warning, when it applies and the studies cited

    LEMON BALM -MELISSA OFFICINALIS

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (EMA 2014).

    Sources cited by Health Canada (1)
    • EMA 2014. European Medicines Agency. Melissae folium.. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 16 June2014. [Accessed 2023 October 27]. Available at: https://www.ema.europa.eu/en/medicines/herbal/melissae-folium

    When using this product exercise caution if you drive or use machinery as you may experience drowsiness (EMA 2014).

    Sources cited by Health Canada (1)
    • EMA 2014. European Medicines Agency. Melissae folium.. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 16 June2014. [Accessed 2023 October 27]. Available at: https://www.ema.europa.eu/en/medicines/herbal/melissae-folium

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 26 April 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Liberdigest transit favorisé: composition and regulation”, https://compoatlas.com/en/supplements/products/362721-liberdigest-transit-favorise, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line